These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12399627)

  • 21. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Sekizuka K; Ebihara I; Koide H
    Am J Nephrol; 2000; 20(5):373-9. PubMed ID: 11092994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6 localization and the prognosis of IgA nephropathy.
    Taniguchi Y; Yorioka N; Kumagai J; Katsutani M; Kuratsune M; Amimoto D; Yamakido M
    Nephron; 1999 Jan; 81(1):94-8. PubMed ID: 9884428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy.
    Peters B; Beige J; Siwy J; Rudnicki M; Wendt R; Ortiz A; Sanz AB; Mischak H; Reich HN; Nasic S; Mahmood D; Persson A; Fernström A; Weiner M; Stegmayr B;
    Nephrol Dial Transplant; 2023 Nov; 38(12):2826-2834. PubMed ID: 37349951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis.
    Bantis C; Heering PJ; Aker S; Klein-Vehne N; Grabensee B; Ivens K
    Kidney Int; 2004 Jul; 66(1):288-94. PubMed ID: 15200436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
    Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
    Kalavrizioti D; Gerolymos M; Rodi M; Kalliakmani P; Provatopoulou S; Eleftheriadis T; Mouzaki A; Goumenos DS
    Cytokine; 2015 Dec; 76(2):260-269. PubMed ID: 26307557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum uric acid and renal prognosis in patients with IgA nephropathy.
    Ohno I; Hosoya T; Gomi H; Ichida K; Okabe H; Hikita M
    Nephron; 2001 Apr; 87(4):333-9. PubMed ID: 11287777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of correlation between urinary IL-6 level and mesangial lesion in childhood onset IgA nephropathy].
    Akutsu Y
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):686-96. PubMed ID: 7959587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping novel immunogenic epitopes in IgA nephropathy.
    Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC; Zhang JJ; Chen M; Lv JC; Liu G; Zou WZ; Zhang H; Zhao MH
    Nephrol Dial Transplant; 2011 Oct; 26(10):3229-36. PubMed ID: 21402675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors affecting the long-term outcome of IgA nephropathy].
    Yang NS; Wu QQ; Du Y; Zhang R; Li YJ; Ye RG; Yu XQ
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.
    Park KS; Han SH; Kie JH; Nam KH; Lee MJ; Lim BJ; Kwon YE; Kim YL; An SY; Kim CH; Doh FM; Koo HM; Oh HJ; Kang SW; Choi KH; Jeong HJ; Yoo TH
    Hum Pathol; 2014 Feb; 45(2):236-43. PubMed ID: 24439222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).
    Yamamoto R; Nagasawa Y; Shoji T; Inoue K; Uehata T; Kaneko T; Okada T; Yamauchi A; Tsubakihara Y; Imai E; Isaka Y; Rakugi H
    Nephrol Dial Transplant; 2009 Dec; 24(12):3686-94. PubMed ID: 19420105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical course and prognostic factors of clinical early IgA nephropathy.
    Shen P; He L; Huang D
    Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary levels of interleukin-8 (IL-8) and disease activity in patients with IgA nephropathy.
    Huang F; Horikoshi S; Kurusu A; Shibata T; Suzuki S; Funabiki K; Shirato I; Tomino Y
    J Clin Lab Anal; 2001; 15(1):30-4. PubMed ID: 11170231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Podocyte injury predicts prognosis in patients with iga nephropathy using a small amount of renal biopsy tissue.
    Hishiki T; Shirato I; Takahashi Y; Funabiki K; Horikoshi S; Tomino Y
    Kidney Blood Press Res; 2001; 24(2):99-104. PubMed ID: 11435741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.